The vascular disrupting agent, DMXAA, directly activates dendritic cells through a MyD88-independent mechanism and generates antitumor cytotoxic T lymphocytes.

Source:http://linkedlifedata.com/resource/pubmed/id/17638914

Cancer Res. 2007 Jul 15 67 14 7011-9

Download in:

View as

General Info

PMID
17638914